The first review! Rundu Pharmaceutical ibuprofen capsules through generic drug consistency evaluation

Pharmaceutical Network August 19 - Zhuhai Rundu Pharmaceutical Co., Ltd(referred to as: Rundu shares) recently received the State Drug Administration approved the issue of the chemical drug "ibuprofen reprieve capsule" of the "drug supplementary application approval", the drug through the quality and efficacy of the drug consistent evaluationAccording to Minet data, in 2018 China's public medical institutions terminal ibuprofen capsule sales of nearly 400 million, Zhuhai Rundu Pharmaceutical sonisted the first companyThe drugbasic information
ibuprofen reprieve capsule is suitable for relieving light to moderate pain such as headache, joint pain, migraine, toothache, muscle pain, nerve pain, pain, and also for fever caused by the common cold or influenzaSales of Ibuprofen capsules in China's public medical institutions (units: 10,000 yuan)Sales of ibuprofen capsules at the end of China's public medical institutions in 2018 were nearly 400 million, up 20.30% Year-on-Year, according to Internet data2018 China's public medical institutions terminal ibuprofen capsule TOP20 brand pattern
in the brand pattern, China and the United States Tianjin Shike Pharmaceuticals market share of the first place, accounting for 43.74 percent, Zhuhai Rundu Pharmaceuticals with 19.22 percent in the second place, the third is the federal pharmaceutical 10.3 percentData show that china and the United States Tianjin Ske Pharmaceuticals market share in recent years has been declining, from 50.59 percent in 2013 to 43.74 percent in 2018, while Zhuhai Rundu Pharmaceuticals grew from 17.70 percent in 2013 to 19.22 percent in 2018, and Federal Pharma grew from 6.97 percent in 2013 to 10.30 percent in 2018Rundu shares said that the product through the product consistency evaluation, market competitiveness further enhanced, can benefit more patients, but also conducive to expanding the market sales of products, the company's operating performance has a positive impact, and for the company's other products to carry out generic drug consistency evaluation work has accumulated valuable experiencedata sources: public company announcement, internet database